1Maruyama R,Toyooka S,Toyoooka KO,et al.Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.Clin Cancer Res,2002,8:514-519 被引量：1
2Salvesen HB,MacDonald N,Ryan A,et al.PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma.Int J Cancer,2001,91:22-26 被引量：1
3Kwong J,Lo KW,To KF,et al.Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.Clin Cancer Res,2002,8:131-137 被引量：1
4Bird A.DNA Mathylation de Novo.Science,1999,286:2287-2288 被引量：1
5Cross SH,Meehan RR,Nan X,et al.A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins.Nature Genetics,1997,16:256-259 被引量：1
7Fujita M,Enomoto T,Haba T,et al.Alteration of p16 and p15 genes in common epithelial ovarian tumors.Int J Cancer,1997,74:148-155 被引量：1
8McCluskey LL,Chen C,Delgadillo E,et al.Differences in P16 gene methylation and expression in benign and malignant ovarian tumors.Gynecol Oncol,1999,72(1):87-92 被引量：1
9Milde-Langosch K,Ocon E,Becker G,et al.p~(16/MIS1) inactivation in ovariancarcinomas high freouency of reduced protein expression associated with hyper-methylation or mugation in endometrioid and mucinous tumors.Int J Cancer,1998,79(1):61-65 被引量：1
10Baldwin RL,Nemeth E,Tran H,et al.BRCA1 promoter region hypermethylation in ovarian carcinoma:a population-based study.Cancer Res,2000,60(19):5329-5333 被引量：1
